V-GATE
LIVE

Serial Number

99386954

Owner

Valink Therapeutics Inc.

Attorney

MATTHEW HOMYK

Filing Date

Sep 11, 2025

Add to watchlist:

No watchlists yet
View on USPTO

V-GATE Trademark

Serial Number: 99386954

V-GATE is a trademark filed by Valink Therapeutics Inc. on September 11, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Valink Therapeutics Inc. (5 trademarks)

2261 Market Street #4161

Entity Type: 03

Trademark Details

Filing Date

September 11, 2025

Registration Date

Not Registered

Published for Opposition

May 26, 2026

Goods & Services

Chemicals for use in industry and science; Biological preparations for use in industry and science; Protein for industrial use; Protein in raw material form for scientific and medical research; Monoclonal antibodies for scientific purposes; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Chemical additives for use in the manufacture of pharmaceuticals; Chemicals for use in the manufacture of pharmaceuticals; Chemicals for use in the manufacture of anti-cancer and chemotherapy drugs; Chemical preparations for scientific purposes

Scientific laboratory services; Scientific and technological services, namely, research and design in the field of biotechnology; Scientific and technological services, namely, research and design in the field of biology; Scientific and technological services, namely, research and design in the field of biochemistry; Scientific and technological services, namely, research and design in the field of pharmaceuticals; Drug discovery services; Biotechnology research; Biological research; Medical research; Clinical research in the field of cancer; Clinical research in the field of biochemistry; Scientific research for medical purposes in the area of cancerous diseases; Vaccine research and development; Pharmaceutical research and development; Research and development services in the field of antibodies; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical drug development services; Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Medical and scientific research, namely, conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others; Testing of pharmaceuticals; Scientific research consulting in the field of biochemistry; Research and development in the field of biochemistry; Biochemical research and analysis; Research and development in the field of biotechnology; Engineering services in the field of biochemistry; Biological research laboratory services; Medical research laboratory services; Laboratory services for biomanufacturing; Laboratory services for the production of pharmaceuticals; Medical research laboratories; Biochemical research; Scientific research consulting in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of pharmaceutical research

Publishing of electronic publications; Publishing and issuing of scientific papers in the field of biochemistry; Publishing and issuing of scientific papers in the field of chemical engineering; Publishing and issuing of scientific papers in the field of biochemical engineering; Publishing and issuing of scientific papers in the field of pharmaceuticals; Publishing and issuing of scientific papers in the field of cancer; Publishing and issuing of scientific papers in the field of medicine; Book publishing; Magazine publishing

Medical services; Pharmaceutical advice; Medical and pharmaceutical consultation; Medical analysis services for the diagnosis of cancer

Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Anti-cancer preparations; Biopharmaceutical preparations for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations for suppressing tumors; Tumor suppressing agents; Chemotherapeutics; Antibodies for medical purposes

Laboratory chemical reactors; Flow meters; Downloadable software for conducting research in chemical engineering; Downloadable software for conducting research in biochemistry; Computer software, recorded, for biochemistry to identify biological characteristics; Computer software, recorded, for chemical engineering to identify biological characteristics; Computer software, recorded, for biochemical engineering to identify biological characteristics; Downloadable software for conducting research in biochemical engineering; Laboratory equipment and supplies, namely, incubators; Computer programs, recorded, for testing chemicals in biochemistry; Computer programs, recorded, for testing chemicals in chemical engineering; Computer programs, recorded, for testing chemicals in biochemical engineering; Computer programs, downloadable, for performing biochemical engineering; Computer programs, downloadable, for performing chemical engineering; Computer programs, downloadable, for performing biochemistry

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 30, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 18, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 17, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 17, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 5, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 5, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 5, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 4, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 3, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 11, 2025 MAFR
NEW APPLICATION ENTERED
Sep 11, 2025 NWAP